Crispr Therapeutics shares owned by Susquehanna International
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Susquehanna International
from 13F filings
Historical chart of Susquehanna International investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Susquehanna International
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $58M | 1.2M | 46.98 |
2024-06-30 | $59M | 1.1M | 54.01 |
2024-03-31 | $93M | 1.4M | 68.16 |
2023-09-30 | $36M | 799k | 45.39 |
2023-06-30 | $47M | 845k | 56.14 |
2023-03-31 | $34M | 760k | 45.23 |
2022-12-31 | $29M | 716k | 40.65 |
2022-09-30 | $56M | 863k | 65.35 |
2022-06-30 | $56M | 918k | 60.76 |
2022-03-31 | $61M | 975k | 62.77 |
2021-12-31 | $102M | 1.3M | 75.81 |
2021-09-30 | $139M | 1.2M | 111.93 |
2021-06-30 | $227M | 1.4M | 161.89 |
2021-03-31 | $187M | 1.5M | 121.83 |
2020-12-31 | $148M | 967k | 153.11 |
2020-09-30 | $51M | 607k | 83.64 |
2020-06-30 | $62M | 843k | 73.49 |
2020-03-31 | $25M | 592k | 42.34 |
2019-12-31 | $48M | 780k | 60.91 |
2019-09-30 | $21M | 522k | 40.99 |
2019-06-30 | $29M | 615k | 47.10 |
2019-03-31 | $26M | 735k | 35.72 |
2018-12-31 | $19M | 658k | 28.57 |
2018-09-30 | $47M | 1.1M | 44.35 |
2018-06-30 | $58M | 983k | 58.76 |
2018-03-31 | $33M | 715k | 45.71 |
2017-12-31 | $3.4M | 146k | 23.50 |
2017-09-30 | $1.4M | 78k | 17.88 |
2017-06-30 | $320k | 20k | 16.00 |